Skip to main content

Table 1 Baseline Characteristics of the cohort/all patients

From: Low molecular weight heparins use in pregnancy: a practice survey from Greece and a review of the literature

Characteristic

N = 818

Age (mean ± SD)

33.9 ± 4.9

BMI (mean ± SD)

24.5 ± 4

No. of fetuses at observed gestation (N, %)

 1

767 (93.8)

  ≥ 2

51 (6.2)

 Delivery by CS (N, %)

644 (78.7)

Reason for enrolling in the study

 Group A: History of VTE (DVT/SVT/Arterial thrombosis/Arterial Ischemia)

76 (9.3%)

 Group B: History of Pregnancy complications

445 (54.4%)

 Group C: IVF

132 (16.1%)

 Group D: Other reasons

165 (20.2%)

Mean Duration of LMWH (months) (mean ± SD)

8.6 ± 1.5

Concomitant Use of ASA (N, %)

152 (18.6)

Mean Duration of ASA (months) (mean ± SD)

6.2 ± 2.7